##semicolon##
Prostata bezi saratoni skriningi, SOD2 geni polimorf lokusi, prostata bezi saratoni rivojlanishi, agressiv prostata bezi saratoni##submission.citations##
Ahmed, H. U., et al. "Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study." The Lancet (2017)
Cybulski, C., et al. (2004). CHEK2 is a multiorgan cancer susceptibility gene. American Journal of Human Genetics, 75(6), 1131–1135.
Franklin, R. B., & Costello, L. C. (2009). The important role of mitochondrial citrate and citrate export in prostate cancer. Molecular and Cellular Biochemistry, 328(1-2), 177–183.
Kasivisvanathan, V., Rannikko, A. S., Borghi, M., et al. (2018). MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis. NewEnglandJournalofMedicine, 378(19), 1767–1777. (Issledovanie PRECISION).
Loeb, S., &Bjurlin, M. A. (2014). Overdiagnosis and Overtreatment of Prostate Cancer. EuropeanUrology, 65(6), 1046–1055.